Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Juveena Hydrogel System Feasibility Study for Heavy Menstrual Bleeding (HMB)

NCT: NCT06634719 · COMPLETED

NCT IDNCT06634719
StatusCOMPLETED
Start Date2025-02-01
Completion2026-05-22
SponsorRejoni Inc. (INDUSTRY)
First posted
Last updated

Brief Summary

This is a prospective, multicenter, single-arm interventional feasibility study to evaluate the safety and feasibility of the Juveena Hydrogel System for temporary control of heavy menstrual bleeding (HMB) in women with a history of chronic ovulatory HMB.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑